A Safety, Tolerability and Pharmacokinetics Study of ZB001 in Healthy Subjects
Clinical trial NCT05542303 · COMPLETED
Trial details
- NCT number
- NCT05542303
- Sponsor
- Zenas BioPharma (USA), LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-16
- Primary completion
- 2023-04-04
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.